The supplied filings document one applicant record for Maxter Healthcare, Inc. at a Rosharon, Texas address, covering a single Class 1 polymer patient examination glove submission under 21 CFR 880.6250. The record set is narrow: one 510(k) entry with a Substantially Equivalent decision, and no recall entries. What follows describes the named applicant, the exact device identity in the filing, and the regulatory pathway it used, without extending those facts to sales, manufacturing capacity or safety performance. [1][6][8]

The applicant and its documented device

Maxter Healthcare, Inc. appears as the applicant on K261793, filed under product code LZA and regulation 21 CFR 880.6250, with the review panel listed as General Hospital. The device name in the record is Powder-free Nitrile Examination Gloves Tested for Use With Chemotherapy Drugs and Fentanyl Citrate (Blue and Black Color). The filing lists a Rosharon, Texas address and a contact name; that address is a filing detail, not a verified headquarters. [1][6][8]

A separate GUDID entry describes a Maxter Blue product, model M, catalog number M93997, as Powder-Free Nitrile Examination Gloves, Non-Sterile, Single Use, Ambidextrous, Disposable Medical Examination Gloves Tested for use with Chemotherapy drugs and Fentanyl Citrate in accordance with ASTM D6978. That entry lists the company as Maxter Healthcare Incorporated, marks the device as OTC and in commercial distribution, and states no natural rubber latex. [7]

Submission dates and review outcome

The 510(k) record gives a date received of 2026-05-29 and a decision date of 2026-09-09, with decision code SESE and the description Substantially Equivalent. The clearance type is Traditional, the third-party review flag is No, and the statement or summary field reads Summary. The advisory committee is listed as HO, General Hospital. [1][6]

The FDA 510(k) database page for K261793 shows a Summary link and repeats the Traditional type and the No answer for third-party review. It also records No for combination product and No for a Predetermined Change Control Plan authorization. The page carries a last-updated date of 10/26/2026. [2]

Classification and product-code context

The device sits in Class 1 under 21 CFR 880.6250, within Subpart G covering General Hospital and Personal Use Miscellaneous Devices, with LZA as the product code. The classification name in the record is Polymer Patient Examination Glove, and the openFDA device name field reads Polymer Patient Examination Glove with device class 1. [6][9]

A third-party index page for K261793 lists the same applicant, product code, decision and decision date, and adds that the gloves are made from Nitrile Rubber Latex (NBR Latex) by continuous dipping, stripped and packed into boxes through an automated manufacturing process. The same page states the gloves are offered in six sizes from X-Small through XXL, in Blue and Black for all sizes. [9]

Establishment listing and corporate references

An FDA establishment registration and device listing result shows MAXTER HEALTHCARE INC, TX/USA, registration 3033715710, year 2026, listed as Manufacturer for polymer patient examination glove entries, including a line for gloves tested for use with chemotherapy drugs. A related listing page carries an updated date of 10/05/2026. [5]

The company website, published by Maxter Healthcare, describes the business as a new vision by Supermax Corporation and presents figures including 30+ years of experience, 1.8M square feet of USA facility, 215 acres of expansion, 100B gloves sold worldwide and 1,200 USA jobs to be created. Those figures are the publisher's own statements and are not corroborated by the FDA records here. The site lists 14559 County Road 48, Rosharon, TX 77583 as its address. [3]